Transplantation as disease modifying therapy in the era of gene therapy medicinal products - health policy considerations
{{output}}
Background: New gene therapy medicinal products [GTMP] are being considered as alternatives to liver transplant [LTx] for some patients with inherited metabolic diseases [IMDs] but pose unique challenges for health policy makers.... ...
